Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-ζ/λ by insulin in vastus lateralis muscles and adipocytes of diabetic rats

Endocrinology

Volumn 142, Issue 4, 2001, Pages 1595-1605

  Kanoh, Y ^a   Bandyopadhyay, G ^a   Sajan, M P ^a   Standaert, M L ^a   Farese, R V ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL KINASE; PROTEIN KINASE B; PROTEIN KINASE C; ROSIGLITAZONE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME SUBUNIT; GLUCOSE TRANSPORT SYSTEM; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; NONHUMAN; PRIORITY JOURNAL; RAT; VASTUS LATERALIS MUSCLE;

EID: 0035053628     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.4.8066     Document Type: Article

References (35)

1. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
2. Thiazolidinedione treatment enhances insulin effects on protein kinase C-ζ/λ activation and glucose transport in adipocytes of nondiabetic and Goto-Kakizaki type II diabetic rats
3. Insulin sensitizer YM268 ameliorates insulin resistance by normalizing the decreased content of Glut4 in adipose tissue of obese Zucker rats
4. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-α on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3/L1 cells
5. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3/L1 adipocytes
6. Regulation of glucose transport by pioglitazone in cultured muscle cells
7. Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents
8. J Clin Endocrinol Metab
9. Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and Glut4 glucose transporter expression in rat skeletal muscle
10. Phosphoinositide 3-kinase: The key switch mechanism in insulin signaling
11. Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling
12. Pioglitazone promotes insulin-induced activation of phosphoinositide 3-kinase in 3T3/L1 adipocytes by inhibiting a negative control mechanism
13. Activation of protein kinase C (α, β, and ζ) by insulin in 3T3/L1 cells
14. Evidence for involvement of protein kinase C (PKC)-ζ and non-involvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes
15. Protein kinase C-ζ as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport
16. Effects of transiently expressed atypical (ζ, λ), conventional (α, β) and novel (δ, ε) protein kinase C isoforms on insulin-stimulated translocation of epitope-tagged Glut4 glucose transporters in rat adipocytes: Specific interchangeable effects of protein kinases C-ζ and C-λ
17. Requirement of atypical protein kinase C-λ for insulin stimulation of glucose uptake but not for Akt activation in 3T3/L1 adipocytes
18. Expression of a constitutively active Akt Ser/Thr kinase in 3T3/L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation
19. Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes
20. Protein kinase B/Akt participates in Glut4 translocation by insulin in L6 myoblasts
21. A role for protein kinase B-β/Akt2 in insulin-stimulated Glut4 translocation in adipocytes
22. Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats
23. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface Glut4 as measured by photoaffinity labeling
24. The thiazolidinedione insulin sensitizer, BRL 49653, increases the expression of PPAR-γ and aP2 in adipose tissue of high-fat-fed rats
25. Insulin activates protein kinase C-ζ and C-λ by an autophosphorylation-dependent mechanism and stimulates their translocation to Glut4 vesicles and other membrane fractions in rat adipocytes
26. Altered regulation of insulin signaling components in adipocytes of insulin-resistant type II diabetic Goto-Kakizaki rats
27. Dependence of insulin-stimulated glucose transporter 4 translocation on phosphoinositide-dependent protein kinase-1 and its target threonine-410 in the activation loop of PKC-ζ
28. Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats
29. Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats
30. Insulin resistance in the GK rat: Decreased receptor number but normal kinase activity in liver
31. Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus
32. 1 hybrids of GK-Wistar rats
33. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
34. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance
35. Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakazaki (GK), obese/aged and obese/Zucker rats